Vor Biopharma (VOR) Retained Earnings (2020 - 2026)
Vor Biopharma (VOR) reported Retained Earnings of -$706000.0 for Q1 2026, up 99.86% year-over-year from -$353254.7 in Q1 2025, and down 1821.95% on a QoQ basis from $41000.0 in Q4 2025.
Vor Biopharma (VOR) has 7 years of Retained Earnings data on file, last reported at -$706000.0 in Q1 2026.
- Quarterly Retained Earnings rose 99.86% year-over-year to -$706000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$706000.0 (up 99.86% YoY) and the FY2025 annual result came in at $41000.0, up 86.36% from the prior year.
- Retained Earnings fell to -$706000.0 in Q1 2026 per VOR's latest filing, from $41000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $41000.0 in Q4 2025 and bottomed at -$2.9 billion in Q3 2025.
- The 5-year median for Retained Earnings is -$250.6 million (2023), against an average of -$448.1 million.
- The widest annual swing landed in 2024, when Retained Earnings jumped 100.01%; it then plunged 562543.68% in 2025.
- Tracing VOR's Retained Earnings over 5 years: stood at -$770000.0 in 2022, then slumped by 44066.23% to -$340.1 million in 2023, then jumped by 100.01% to $22000.0 in 2024, then jumped by 86.36% to $41000.0 in 2025, then plunged by 1821.95% to -$706000.0 in 2026.
- Per Business Quant, the three latest VOR Retained Earnings figures stand at -$706000.0 (Q1 2026), $41000.0 (Q4 2025), and -$2.9 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Vor Biopharma | 628.83 Mn | 628.83 Mn | - | -706,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -706,000.00 |
| Dec 31, 2025 | 41,000.00 |
| Sep 30, 2025 | -2.88 Bn |
| Jun 30, 2025 | -2.06 Bn |
| Mar 31, 2025 | -489.50 Mn |
| Dec 31, 2024 | 22,000.00 |
| Sep 30, 2024 | -426.28 Mn |
| Jun 30, 2024 | -398.70 Mn |
| Mar 31, 2024 | -87,000.00 |
| Dec 31, 2023 | -340.08 Mn |
| Sep 30, 2023 | -313.82 Mn |
| Jun 30, 2023 | -280.63 Mn |
| Mar 31, 2023 | -250.65 Mn |
| Dec 31, 2022 | -770,000.00 |
| Sep 30, 2022 | -1.18 Mn |
| Jun 30, 2022 | -174.52 Mn |
| Mar 31, 2022 | -1.07 Mn |
| Dec 31, 2021 | -130.12 Mn |
| Sep 30, 2021 | -111.87 Mn |
| Jun 30, 2021 | -93.32 Mn |
| Mar 31, 2021 | -74.95 Mn |
| Dec 31, 2020 | -61.22 Mn |